Corcept Therapeutics | CORT - EPS Earnings Per Share

Stock Price
46.16
Daily Change
-0.43 -0.92%
Monthly
14.51%
Yearly
-35.42%
Q2 Forecast
45.07

Corcept Therapeutics reported $0.2 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -0.11 0.17 Apr/30
FY2025Q4 Dec/2025 0.20 0.38 0.26 Feb/24
FY2025Q3 Sep/2025 0.16 0.17 0.41 Nov/04
FY2025Q2 Jun/2025 0.29 0.38 0.32 Jul/31
FY2025Q1 Mar/2025 0.17 0.15 0.25 May/05




Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
ANI Pharmaceuticals USD 2.33 0.29 Dec/2025
Ardelyx USD 0 0 Dec/2025
Assertio Holdings USD -0.03 0.01 Sep/2024
Aurora Cannabis CAD -0.64 0.36 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Canopy Growth CAD -0.05 0.03 Dec/2025
Corcept Therapeutics USD 0.2 0.04 Dec/2025
Eli Lilly USD 8.55 1.01 Mar/2026
Esperion Therapeutics USD 0.26 0.42 Dec/2025
J&J USD 2.7 0.24 Mar/2026
Knight Therapeutics CAD -0.09 0.12 Dec/2025
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Merck USD -1.28 3.32 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Novartis USD 1.99 0.04 Mar/2026
Novartis USD 1.99 0.45 Mar/2026
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.06 0.64 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025
TG Therapeutics USD 0.14 2.29 Dec/2025